ClpA and ClpX, the regulatory components of the ATP-dependent ClpAP and ClpXP proteases, are members of the Clp/Hsp100 family of molecular chaperones, which play important roles in protein quality control and regulatory protein degradation (1, 2) . Specific proteins targeted for regulatory unfolding or degradation are recognized by virtue of sequence or structural motifs located in accessible regions near their amino or carboxy termini. Clp chaperones can also target aberrant or altered forms of virtually any cellular protein either through weak interaction with unfolded regions of the protein or by more specific recognition of motifs that become exposed in the protein or are added to the protein as degradation tags by other enzymatic systems. The specific motifs or degradation tags are either directly recognized by sites in ClpA or ClpX or are recognized by one of several adaptor proteins that associate with ClpA or ClpX, and, in some instances, different parts of the tag can be recognized by the chaperone and the adaptor (3) (4) (5) .
Among the substrates for ClpAP in E. coli are proteins degraded by the N-end rule pathway (6) . The N-end rule relates the stability of a protein to its N-terminal residue. A destabilizing N-terminal residue is referred to as an N-degron (7), when it is recognized by a component of a degradative system and is sufficient to target the protein for degradation. In E. coli, the N-degrons include phenylalanine, tyrosine, tryptophan, and leucine (6) . Arginine and lysine serve as secondary destabilizing residues, because proteins with these residues at the N-terminus are modified by Leu/Phe-tRNA protein transferase to generate an N-degron by post-translational attachment of phenylalanine or leucine (8, 9) . Destabilizing residues are usually not found at the N-terminus of newly synthesized proteins in vivo, because protein biosynthesis usually begins with methionine, and the N-terminal methionine is not removed by methionine aminopeptidase when one of these residues is in the second position (10) . Initially, components of the N-end rule pathway in E. coli were identified using proteins engineered to display N-degrons (6, 8) . Recently, however, endogenous substrates degraded by the N-end rule have been identified in E. coli (11) (9) . In at least one case, an aminopeptidase generates a protein with an N-degron that is degraded by ClpAP (11) (9, 12) , but the mechanisms by which N-end rule substrates are formed and the frequency with which they occur are largely unknown.
In E. coli, proteins with N-degrons are recognized by a small protein, ClpS, which binds the N-degron and delivers the protein to ClpAP (5) . ClpS is a highly conserved and has sequence homology to a domain found in the E3 ligases of yeast and mammals, which recognize N-degrons (13) . ClpS is expressed in an operon with ClpA and is required for rapid degradation of proteins with N-degrons in vivo. Purified ClpS is a monomer with a single binding site for an Ndegron (12, (14) (15) (16) . Peptides with Phe, Tyr, Trp, or Leu at the N-terminus bind to ClpS, and similar peptides with other N-terminal residues bind with substantially lower affinity (5) . The crystal structure of ClpS with a bound peptide bearing an N-degron shows the hydrophobic side chain of the N-degron pointing into a deep hydrophobic pocket in ClpS and the α-amino group of the peptide forming an ion pair with an acidic residue on the rim of the hydrophobic pocket (12, 16) . Other contributions from hydrogen bonding between the main chain carbonyls and amides are limited and non-specific. In vitro, ClpS increases the catalytic efficiency of ClpAP against proteins with Ndegrons (5), while inhibiting the degradation of proteins with other degradation motifs (14, 15) . Details of how ClpS interacts with the ClpAP holoenzyme complex and performs its functions are not well understood.
The holo-enzyme complex of ClpAP is a barrel-like complex. The center has two heptameric rings of ClpP subunits stacked face to face. The ClpP rings are flanked on either side by axially aligned hexameric rings of ClpA (17, 18) . ATP binding to ClpA is required to stabilize the ClpA hexamers and to maintain the ClpAP complex. ClpA subunits contain three tandem domains: an N-domain and two non-identical ATPase domains (NBD1 and NBD2) (19) . In the ClpA hexamer, NBD1 and NBD2 form separate homomeric rings superimposed on each other. The NBD2 ring makes the contact with ClpP, while NBD1 forms the distal ring. The N-domain folds independently and is connected to NBD1 by a flexible linker (19) . Electron microscopic studies suggest that the N-domains are mobile and occupy multiple positions above surface of the NBD1 ring (20) . The N-domain binds unfolded proteins, which serves to recruit substrates to NBD1 and to slow the release of proteins unfolded by ClpA. The N-domain also binds ClpS. Substrates bound to the N-domain or to ClpS are handed off to the ATPase domains, unfolded, and translocated via an axial pathway into ClpP.
Both ClpS and the isolated ClpA N-domain are monomers and form a tight 1:1 complex when mixed in vitro (15, 21) . Thus, up to six molecules of ClpS might be expected to bind to assembled ClpA hexamers. The binding of multiple molecules of an adaptor and its substrate cargo raises a question as to the efficiency of substrate delivery and processing by hexameric ClpA. The ClpA axial channel appears too narrow to allow translocation of more than one protein at a time, which suggests that a mechanism to limit the binding or transfer of bound substrate to the unfolding and translocation apparatus would be needed to prevent steric clashes between multiple bound substrates and to improve overall efficiency. In fact, several observations suggest that the geometry of interaction of ClpS with assembled ClpA or structural changes subsequent to binding might affect the binding stoichiometry and activity. In the crystal, the mobile N-terminal 17 amino acids of ClpS (ClpS-N1-17) extend out from the complex, and residues 3-8 interact with another ClpA N-domain. ClpS-N1-17 is not needed for binding to N-domains but is required for inhibition of activity against substrates such as SsrA-tagged proteins (15) . ClpS-N1-17 is also needed for activation of N-end rule degradation (22) , and it has been proposed that ClpS-N1-17 interacts within or near the axial channel of ClpA.
To learn more about the interaction of ClpS with ClpA and the mechanisms by which it affects ClpA activity, we investigated whether ClpS can bind to all six N-domains in a ClpA hexamer and how many ClpS molecules are needed for optimal activation or inhibition of protein degradation. Here we show that one molecule of ClpS binds to a ClpA hexamer with high affinity, and that only one ClpS molecule is required for maximum stimulation or inhibition of degradation. We propose that ClpS allosterically affects the structure of ClpA hexamers and reorganizes the Ndomains to reduce the number of ClpS molecules that can bind.
MATERIALS AND METHODS
Plasmid clones and protein expression. ClpA, ClpP, and ClpS were expressed and purified as described (15, 23, 24) . ClpA-Δ153 (25), the phage P1 RepA protein (26) , and GFP-SsrA (27) were expressed and purified as described. To clone the SUMO-LR-GFP Venus fusion protein, we first amplified the GFP Venus coding region in plasmid pVenus-N1-NPY (28) with primers (5'-cttagaaaagg agaagaacttgttactggagttgtggtgagcaagggcgaggagctg and 3'-ttacttgtacagctcgtccatgccgagagtgatc). The forward primer added the coding region for 11 amino acids (LRKGEELVTGV) to the coding region of GFP Venus . The product was ligated to the Champion SUMO expression vector (Invitrogen) by TA cloning. The new ORF encoded a fusion protein with His 6 -SUMO linked to LR-GFP Venus . The plasmid was transformed into E. coli BL21-DE3 cells. Cells were grown in LB plus ampicillin and ITPG was added at mid-exponential phase to induce expression for 4 hours. Cells were harvested and frozen until used. After suspension in 50 mM Tris/HCl, pH 7.5, with 10% (v/v) glycerol, the thawed cells were lysed by a single pass through a French pressure cell at 20,000 psi. Cell debris was removed by centrifugation at 30,000 x g for 60 minutes, and the clear supernatant solution was passed over a 10-ml bed Talon metal chelate affinity resin. After washing the column with 5 column volumes of buffer, the bound protein was eluted with 10 aliquots of 2 ml each of 0.2 M imidazole in 50 mM Tris/HCl, pH 7.5, with 10% (v/v) glycerol. Fractions with the SUMO-LR-GFP Venus fusion protein were pooled and dialyzed against buffer without imidazole. The fusion protein was cleaved with 50 µg Sumo hydrolase (29) per mg SUMO-LR-GFP Venus by incubation for 6 h at 4 °C. The solution was passed through a 10-ml bed of Talon resin and the unbound LR-GFP Venus was collected.
[ Protein and enzymatic assays. Protein concentrations were measured by absorbance using either experimentally determined absorption coefficients (23, 29) or absorption coefficients calculated from the aromatic amino acid content using the Pepstats program (http://helixweb.nih.gov /emboss/html/pepstats.html). For routine assays or in the presence of substances that interfere with absorbance measurements, a dye-binding assay (BioRad) was used after calibration with known stock solutions of the particular protein. Protein concentrations are expressed in molar units of the native solution structure of the protein-hexamers of ClpA, tetradecamers of ClpP, monomers of ClpS or isolated ClpA-N-domain, and so on. Fluorescence measurements for LR-GFP Venus were made using an Aminco Bowman Spectrofluorometer with excitation at 490 nm and emission at 528 nm (2-4 nm bandwidth). For GFPSsrA fluorescence measurements, excitation was at 394 nm and emission was at 509 nm with 2 nm bandwidth.
Degradation of radioactively labeled proteins was measured by release of trichloroacetic acidsoluble counts as described previously (23 Other analytical methods. Analytical gel filtration was performed at room temperature using a Superdex200 or Superdex75 column (3 mm x 25 cm) (Pharmacia). Columns were run in 50 mM Tris/HCl, pH 7.5, 0.1 M KCl, and 10% (v/v) glycerol at a flow rate 0.04-0.08 ml/min. ATPγS (1 mM) and MgCl 2 (20 mM) were added to buffers as required for specific experiments. Protein absorbance was monitored at 235 and 280 nm in the absence of nucleotide and at 295 nm when nucleotide was present. When needed, fractions were collected manually at 1 min intervals. SDS-PAGE was performed using pre-cast Novex 4-20% polyacrylamide gels in the BisTris/MES buffer system as described by the manufacturer. Proteins were stained with Coomassie blue. To quantitate proteins in gel filtration fractions, equal aliquots were run in each lane, digital images of the gels were recorded, and the intensities of the stained protein bands were measured using NIH Image software. To compare the distribution of ClpS in different experiments, the ClpS intensities in the fractions within a given run were summed and normalized to the amount of ClpS loaded on the column.
RESULTS

ClpS mediates interaction of N-end rule proteins with
ClpA. Based on the reported specificity of ClpS in targeting proteins for degradation by ClpAP, we constructed the substrate, LR-GFP Venus , which has an N-terminal leucine followed by arginine. LR-GFP Venus was degraded by ClpAP in the presence of ClpS but was not degraded in the absence of ClpS (Table 1 and Supplementary Fig. S1 ). To confirm the importance of the N-terminal amino acid in allowing ClpS to target LR-GFP Venus to ClpAP, we synthesized several peptides with N-degrons and determined their ability to bind to ClpS and inhibit degradation of LR-GFP Venus . The peptides, LRKGE and FKTA, displayed monotonic binding isotherms with one molecule of peptide bound per ClpS ( Supplementary Fig. S2, A and B) . The K d for binding was 3.0 µM for LRKGE and 3.5 µM for FKTA. Virtually identical data were obtained for binding of the peptides to the heterodimeric complex of ClpS and isolated ClpA N-domain ( Supplementary Fig. S2, C and D) . Variants of the peptides with N-terminal serine or methionine residues (SLRKGE, MLRKGE, and MYVLVQ) showed no evidence of binding at concentrations ≤30 µM (data not shown).
When added at saturating levels, LRKGE, FKTA, and YVLVQ completely inhibited ClpSmediated degradation of LR-GFP Venus by ClpAP (Table 1) ; half-maximal inhibition occurred at ~1 µM peptide (Table 1) , consistent with the dissociation constants measured by direct binding. None of the peptides inhibited degradation of the non-N-end rule substrate, GFP-SsrA, by ClpAP (Table 1 ). Peptide variants with N-terminal serine or methionine residues had no inhibitory activity in either assay at concentrations up to 30 µM. We conclude that degradation of LR-GFP Venus by ClpAP is dependent on recognition of the Ndegron by ClpS.
Non-equivalent binding of ClpS to ClpA hexamers. If ClpS binds to the N-domains in
ClpA 6 in the same manner as it binds to the isolated N-domain, each hexamer of ClpA could bind up to six ClpS monomers. However, neither the substrate saturation curve for LR-GFP Venus nor the peptide inhibition curves gave indications of multiple binding sites ( Supplementary Fig. S1 ). To address the question of how many ClpS molecules bind to assembled ClpA hexamers and are required for activity, we measured binding of ClpS to ClpA 6 and then determined the binding stoichiometry needed for expression of ClpS activities.
To isolate tight-binding complexes of ClpS and ClpA 6 , we initially assembled ClpA 6 in the presence of ATPγS, incubated it with increasing amounts of ClpS, and passed the mixtures over a gel filtration column under conditions in which ClpA remained hexameric. When one equivalent of ClpS was added per ClpA 6 (Fig. 1A, circles) , essentially all the ClpS co-migrated with ClpA 6 , indicating that the complex was very stable. When 2 equivalents of ClpS were added (Fig. 1A  triangles) , only about two-thirds of the ClpS remained bound to ClpA 6 , and a significant amount was found as free ClpS. Addition of more than three equivalents of ClpS (Fig. 1A squares) did not increase the amount of ClpS bound to ClpA 6 , and the excess ClpS migrated as the unbound protein. These data suggested that only 1-2 molecules of ClpS bind tightly enough to ClpA 6 to remain bound during gel filtration, and any additional molecules that bind do so with lower affinity and dissociate during gel filtration.
To quantitate binding between ClpS and ClpA 6 directly, we measured [ 3 H]ClpS bound to ClpA 6 following ultrafiltration through 30,000 MW cut-off membranes. To minimize dissociation of the complex, the samples were centrifuged for only 30 sec. A Scatchard plot of the binding data is shown in Fig. 1B . Binding was biphasic, indicating more than one binding interaction. Extrapolation of the steep portion of the line to the abscissa showed that ~1 molecule of ClpS per ClpA 6 was bound with high affinity, and the K d , obtained from the slope of the line, was ~40 nM. The slope of the shallower portion of the line indicates the presence of weaker binding sites with K d >700 nM. Extrapolation of this segment to the axis indicated two or more additional ClpS molecules bound, but the exact number of ClpS molecules binding with low affinity cannot be determined by this method, because rapid dissociation prevents retention of some of the weakly bound species. These data indicate that the mode of binding of the first molecule of ClpS to ClpA 6 differs from the binding of subsequent molecules.
The N-terminal portion of ClpS is needed for asymmetric binding of ClpS to ClpA 6 . The Nterminal portion of ClpS (residues 1-17) is an extended, mobile polypeptide that is important for inhibitory activity (15, 22) and is required for efficient degradation of proteins bearing Ndegrons (5, 22) . To determine if the ClpS Nterminal region affects binding to ClpA 6 , we generated ClpS-Δ17 by tryptic cleavage and removed the N-terminal peptide by gel filtration (15) . Co-migration of ClpS-ΔN17 with ClpA 6 during gel filtration indicated that binding of ClpS-ΔN17 was significantly weaker than binding of intact ClpS. Very little ClpS-ΔN17 co-migrated with ClpA 6 when added at a 3:1 ratio (Fig. 1C , circles) and at 6:1 about two molecules of ClpS-ΔN17 were found with ClpA 6 (Fig. 1C, triangles) . Approximately four molecules of ClpS-ΔN17 comigrated with ClpA 6 when excess ClpS-ΔN17 was added (Fig. 1C , squares and inverted triangles). Trailing of the ClpS-ΔN17 in the fractions after the ClpA 6 /ClpS complex suggested that more than four molecules might be bound under equilibrium conditions.
Binding measurements using the ultrafiltration assay confirmed that [ 3 H]ClpS-ΔN17 binds more weakly to ClpA 6 than does intact ClpS. In a Scatchard plot (Fig. 1D) , the data were fit by a simple linear regression, consistent with a single type of binding site, which gave a K d of ~ 1.0 µM. Thus, ClpS-ΔN17 binds with about one-tenth the affinity of ClpS. Extrapolation of the line to the axis indicated that 4 or more molecules of ClpS-ΔN17 can bind per ClpA 6 . The difference in binding between ClpS and ClpS-ΔN17 suggests that some part of the N-terminus of ClpS contributes directly or indirectly to ClpS binding to a high affinity site on ClpA 6 ; this ClpA site is occupied by only one ClpS molecule at a time.
Competition between ClpS and ClpS-ΔN17 for binding to ClpA6. (Fig, 2A) , and up to a 24-fold excess of ClpS-ΔN17 caused <30% inhibition. A 60-fold excess of ClpS-ΔN17 was needed to achieve 80% inhibition of binding.
In separate experiments, we also found that ClpS-ΔN17 competes poorly with ClpS under assay conditions, and that >10-fold excess of ClpS-ΔN17 was needed to block ClpS activity in either activating LR-GFP Venus degradation or inhibiting GFP-SsrA degradation ( Supplementary Fig. S3 ). Together, these data confirm that, under exactly the same conditions, ClpS-ΔN17 cannot compete with ClpS for the same high affinity site in ClpA 6 . Displacement of nearly half of the [ 3 H]ClpS by one equivalent of non-labeled ClpS also confirms that the first ClpS goes to a high affinity site, and that competition for that site occurs at low concentrations of ClpS insufficient to saturate the binding sites on the other N-domains of ClpA 6 .
ClpS binds with higher affinity to the tight site on ClpA 6 than to free ClpA N-domain. Binding competition assays were conducted as above, except that [ 3 H]ClpS was mixed with free ClpA Ndomains and then added to ClpA 6 . With free Ndomains equimolar with N-domains in ClpA 6 , ~15% inhibition of ClpS binding was observed (Fig. 2B ) rather than the 50% expected if free Ndomains bound with the same affinity as the Ndomains in ClpA 6 . With N-domains in 24-fold excess over [ 3 H]ClpS (4-fold excess over the Ndomains in ClpA 6 ), only 25% inhibition was seen, and a 60-fold excess (10-fold over total Ndomains in ClpA 6 was needed to competitively bind >80% of the [ 3 H]ClpS (Fig. 2B) . We also tested the ability of free N-domains to block the interaction between ClpS and ClpA 6 under assay conditions. In degradation reactions in which ClpS was limiting, a large excess of free N-domains over the total N-domains in ClpA 6 was needed to block ClpS-mediated degradation of LR-GFP Venus or inhibition of GFP-SsrA degradation ( Supplementary Fig. S3) .
One ClpS molecule has a low off rate from ClpA 6 3C ). To confirm that ClpS dissociation from ClpA 6 is also slow under assay conditions, we initiated a ClpS-dependent degradation reaction and added excess free ClpA N-domain to trap any ClpS that dissociated, which was measured by the decrease in the rate of degradation of LR-GFP Venus . The degradation reaction slowed with first order kinetics and the half time for dissociation of ClpS was ~ 2 min (Fig. 3D) . The slightly faster off rate likely reflects the higher temperature under assay conditions (37 versus 25 °C) and the presence of hydrolyzable ATP, which renders ClpA hexamers more dynamic than when non-hydrolyzable ATPγS is present. The similarity in dissociation rates measured by direct binding and by loss of function suggested that activity of ClpS is dependent on one tightly bound molecule.
Maximum degradation of N-end rule proteins occurs with one ClpS per ClpA 6 . To determine the optimum amount of ClpS needed to promote degradation of the N-end rule substrate, LR-GFP Venus , ClpP was kept in excess so that activity was limited by ClpA or ClpS. Assay sets contained a fixed concentration of ClpA 6 and varying amounts of ClpS. Plots of specific activity (µmol substrate/min/µmol ClpA 6 ) versus ClpS with ClpA 6 present at 100-300 nM gave the same specific activity of ClpA 6 at saturating ClpS (Fig. 4A) . Several kinetic models were tested, but good fits were obtained only by fitting the data to a model of simple saturation binding to a single binding site. The K d for activation by ClpS varied between 10 and 40 nM in assays with different concentrations of ClpA 6 . When lower concentrations of ClpA 6 were used, the concentration of ClpS required to reach saturation was higher than that of ClpA 6 (Fig.  4A, circles, squares, and diamonds) , which reflects the need for free ClpS to be in ~10-fold excess of the K d to reach 90% saturation and does not indicate higher stoichiometry of binding. To confirm that a 1:1 stoichiometric ratio of ClpS to ClpA 6 is sufficient for activation, 0.4 µM ClpA 6 was used in the assays, a concentration that is >20 times the K d for ClpS binding to the high affinity site, so that essentially all the ClpS would be bound to the high affinity sites. Under these conditions, maximal activity was obtained with one equivalent of ClpS (Fig. 4A, inverted triangles) . Addition of more ClpS did not stimulate activity further, and higher amounts began to inhibit the reaction, presumably as free ClpS competed with ClpAbound ClpS for the substrate. For assays conducted in this manner, the kinetics of the reaction were analyzed during the linear range only (first 30 sec), before excess depletion of ATP or the substrate.
ClpS binds a single molecule of N-end rule substrate (12, 16) . To test whether the efficiency of substrate delivery was dependent on the number of ClpS bound to ClpA 6 , we measured degradation as a function of LR-GFP Venus concentration with different stoichiometric ratios of ClpS to ClpA 6 . The V max obtained was the same for one ClpS bound to ClpA 6 as for higher ratios of ClpS, and the apparent K m for LR-GFP Venus was essentially the same with different amounts of ClpS present (Fig. 4B) .
One N-domain of ClpA per hexamer is sufficient for maximum ClpS-dependent degradation of N-end rule substrates. ClpA-Δ153, which lacks the entire N-terminal domain, assembles into hexamers, interacts with ClpP, and activates ATP-dependent protein degradation by ClpP (24, 25) . Because ClpS binds to the N-domain of ClpA, ClpA-Δ153 is insensitive to ClpS as an inhibitor of non-N-end rule substrate degradation (14) . As a measure of the efficiency of N-end rule substrate delivery by ClpS, we assembled mixed hexamers containing intact ClpA and ClpA-Δ153 and compared degradation activity against LR-GFP Venus with and without ClpS. As expected, hexamers composed entirely of intact ClpA had no activity in the absence of ClpS but showed high activity when ClpS was present (Fig. 5A) . Hexamers composed of only ClpA-Δ153 had some activity against LR-Venus, but ClpS has no effect on that activity (Fig. 5A) . Mixed hexamers containing one to four ClpA-Δ153 subunits had almost no activity in the absence of ClpS but were highly activated by ClpS. Even with at a ratio of 1 ClpA to 11 ClpA-Δ153, when most hexamers would have no more than one N-domain, degradation was highly activated by ClpS (Fig.  5A ). In panel B of Fig. 5 , the ClpS-dependent activity, calculated from the difference between the activities with and without ClpS in Fig. 5A , are plotted and compared to activities expected when either one (dotted line) or two (dashed line) Ndomains per hexamer are required for ClpSmediated degradation. For this analysis, the subunits were assumed to assume a binomial distribution and the positions within the hexamers were assumed to have no influence on activity. The experimental data fall between the two calculated curves but closer to that predicted if only one Ndomain were required. The calculated specific activity for hexamers with one N-domain was the same as that of hexamers containing six Ndomains, consistent with a single N-domain with ClpS bound being sufficient to promote maximum activity in degrading N-end rule substrates.
One ClpS per ClpA 6 is sufficient to inhibit degradation of non-N-end rule proteins. To determine the binding stoichiometry needed for maximum inhibition by ClpS, we needed to consider the degree of saturation with ClpS and the possibility of competition between ClpS and substrates (30) . We assayed GFP-SsrA degradation, which is inhibited by ClpS with a K I of ~30 nM (Table 1) . With a moderate amount (100 nM) of ClpA in the assay and substrate added in excess of its K m , the apparent K I was ~60 nM and the amount of ClpS required to completely inhibit degradation was in excess of the ClpA 6 (Fig. 6, open circles) . To achieve nearly complete inhibition with a stoichiometric ratio of ClpS to ClpA 6 required adding ClpA 6 far in excess of the K d for the ClpS/ClpA 6 interaction. With 400 nM ClpA 6 and 400 nM ClpS inhibition was only partial when the substrate and ClpS were added simultaneously (Fig. 6, open triangles) . However, when we preincubated ClpS and ClpA to allow the tight complex to form before adding substrate, the activity against GFP-SsrA was completely inhibited (Fig. 6, closed symbols) . For this determination, we also restricted the assay time to 30 sec to avoid significant dissociation of the ClpS from ClpA 6 during the reaction. Thus, the complex with one molecule of ClpS bound to ClpA 6 is not only sufficient to activate N-end rule protein degradation but also blocks heterologous protein substrates from being degraded.
Kinetics of inhibition by ClpS is dependent on the substrate. Because the ClpA N-domains affect the kinetics of unfolding or degradation of different substrates in different ways ( (24); and below), we considered that ClpS, which exerts its effects in part by binding to the N-domains, might also display variable kinetics of inhibition depending on the substrate. ClpS acted as a mixed competitive inhibitor of casein degradation (Fig. 7A) . Both ClpS and casein bind to the ClpA N-domains, and mixed inhibition could result from partial overlap of the binding sites that allows either protein to weaken the binding of the other. Alternatively, ClpS and casein could bind to one or more of the six N-domains in the same hexamer and sterically interfere with formation of a productive complex of the other protein. ClpS acted as a non-competitive inhibitor of GFP-SsrA degradation (Fig. 7B) . This finding was somewhat surprising, since ClpS can block the binding of SsrA-tagged proteins (see below). Non-competitive inhibition implies that ClpS can interact with the GFP-SsrA/ClpA complex to prevent processing of the substrate. This mechanism is possible, because GFP-SsrA does not appear to interact with the N-domains (24), which are the major entry site for binding of ClpS to ClpA hexamers. As shown below, ClpS remains bound to ClpA 6 in the presence of excess GFP-SsrA.
To directly determine competition between ClpS and non-N-end rule proteins for binding to ClpA 6 , we measured binding by retention of the different proteins in the ClpA 6 fractions after gel filtration. Binding CI-SsrA and RepA (Fig. 8) as well as α-casein (data not shown) was diminished or completely blocked in the presence of ClpS. With CI-SsrA, binding was inhibited >80% by ClpS present at one molecule per ClpA 6 (Fig.8A) . ClpS blocked CI-SsrA binding whether it was added before (open triangles), after (closed triangles), or simultaneously with (closed circles) CI-SsrA. Interestingly, when ClpS is bound to ClpA 6 , addition of excess GFP-SsrA did not displace the ClpS (data not shown). The binding of ClpS in the presence of an excess of GFP-SsrA is consistent with its acting as a non-competitive inhibitor of GFP-SsrA degradation (Fig. 7B) . Competition between ClpS and RepA was dependent on the order of addition (Fig. 8B) .
Addition of ClpS prior to (open circles) or
simultaneously with (open triangles) RepA blocked binding of RepA but when RepA was incubated with ClpA prior to addition of ClpS, RepA was retained with ClpA. RepA binding to ClpA is known to undergo a change from a reversible mode to a "committed" mode in which RepA has a much reduced off-rate from ClpA. ClpS apparently cannot disrupt the committed mode of RepA binding although it can prevent its formation. ClpS does not bind well to the committed complex of RepA and ClpA (data not shown), probably because, although the N-domains are not needed for RepA binding, once RepA is bound, it interacts with the N-domains of ClpA and reduces their availability to ClpS.
On the basis of the inhibition data, we propose that ClpS binding to the N-domains allows the Nterminal peptide to engage an additional site. Once tightly bound, ClpS prevents substrates from entering the axial channel and accessing protein interaction sites required for tight binding of substrates such as GFP-SsrA and RepA. Inhibition of casein degradation is partially competitive because both proteins bind to the N-domains of ClpA, whereas competition is non-competitive with GFP-SsrA because GFP-SsrA cannot block ClpS from binding the N-domains and gaining access to its tight binding site. Competition between RepA and ClpS is complicated because RepA binding proceeds in multiple steps. ClpS competes effectively with the fast reversible step in RepA binding but cannot reverse the committed binding mode once it has occurred. Consistent with this model, ClpS blocks RepA degradation very effectively when added to assay mixtures simultaneously with RepA; however, ClpS allows the degradation of most of the RepA preloaded onto ClpA prior to addition of ClpS ( Supplementary Fig. S1 ). ClpS binds weakly to committed ClpA/RepA complexes (data not shown), most likely because RepA in such complexes engages the ClpA N-domains and prevents ClpS from binding and forming the inhibitory complex.
In the absence of ClpS, the ClpA N-domains have variable effects on protein degradation. In the absence of ClpS, ClpAP degrades various proteins with accessible N-terminal or C-terminal degradation signals as well as unfolded proteins or proteins with unstructured regions. In a previous study, we showed that, when the N-domain of ClpA was deleted, the V max for degradation of both folded and unfolded proteins was higher, and the K m for the unfolded substrate, α-casein, was also 10-fold higher (24) . To address the effects of the Ndomains in more detail, we compared the kinetics of degradation by ClpAP and ClpAΔ153/ClpP using three different substrates. When RepA was used as the substrate, the K m and V max were essentially the same with wild type ClpA and ClpA-Δ153 (Table 2 ; Supplementary Fig. S2 ). Consistent with our previous study (24) , activity against casein and GFP-SsrA was two to three times higher with ClpA-Δ153 than wild type ClpA (Supplementary Fig. S2 ). The K m for casein was increased by a factor of ≥ 10 in the absence of the N-domains, while the K m for GFP-SsrA was unaffected ( Table 2 ). The K m s in this work were slightly lower than reported previously, because the current assays were done in the absence of detergent, which affects substrate binding. To confirm that the change in K m for casein when the N-domains are missing reflects reduced binding affinity, we compared the ability of casein to inhibit GFP-SsrA degradation by ClpAP with or without N-domains. Casein competitively inhibited GFP-SsrA degradation by full-length ClpAP with an apparent K I of 0.9 µM, close to its K m as a substrate; the K I for casein increased to ~10 µM when ClpA-Δ153 was used, close to the observed K m for casein degradation in the absence of the Ndomains (Table 2 ; Supplementary Fig. S1 ).
To determine whether the N-domains act in concert or individually during protein degradation, we formed mixed hexamers of full-length ClpA and ClpA-Δ153 and measured activity against casein and GFP-SsrA. The V max for degradation of both substrates increased as the number of ClpA-Δ153 subunits increased (Table 3) , and, for casein, the K m showed an incremental increase as Ndomains were removed. Because the kinetic properties changed in proportion to the number of N-domains removed, we propose that the Ndomains each can bind unfolded proteins, which serves to recruit unfolded substrates, but they also bind proteins as they are unfolded by ClpA, resulting in slower release to the translocation apparatus.
DISCUSSION
ClpS is a specific adaptor protein that redirects the activity of ClpAP toward proteins that contain exposed N-terminal leucine, phenylalanine, tyrosine, or tryptophan residues (N-degrons) (5, 11, 12) . In our study, LR-GFP Venus , which carries an N-degron but no other recognition motif, was degraded by intact ClpAP in the presence of ClpS but not by ClpAP alone. Short peptides with leucine or phenylalanine at the N-terminus were effective inhibitors of LR-GFP Venus degradation, but the presence of a single hydrophilic residue at the N-terminus of the peptides rendered them completely ineffective as inhibitors. These data are consistent with other studies showing that ClpS is needed to mediate degradation of proteins targeted by virtue of an N-degron (5, 11, 12, 16) .
ClpAP is not restricted to degrading proteins with N-degrons and will degrade unfolded proteins and proteins with unstructured polypeptide regions near their N-or C-termini (31) (32) (33) or, less efficiently, internal regions as in unstructured linkers between protein domains (34) . Degradation based on accessible hydrophobic regions is dependent on the binding of substrates to the Ndomains of ClpA or to sites within the axial channel of ClpA. Axial binding sites in ClpA have been shown to bind hydrophobic peptides (35, 36) , and they serve by unknown mechanisms in formation of committed substrate enzyme complexes, possibly by capturing proteins with unstructured N-or C-terminal regions that can extend into the axial channel as suggested for similar loops in ClpX (37) . ClpS inhibits degradation of substrates with these more general hydrophobic motifs by competitively blocking substrate binding to the ClpA N-domains or by blocking direct access to binding sites within the axial channel. Thus, ClpS acts as a gatekeeper for ClpAP, making it highly specific for proteins with N-degrons. Some proteins possess both an Ndegron and an unstructured and hydrophobic N-or C-terminal region. ClpAP will degrade such proteins in the absence or the presence of ClpS using either mode of substrate recognition (30) .
Our data show that when ClpS binds to ClpA hexamers, one molecule of ClpS binds more tightly than was observed for ClpS binding to isolated N-domains. Additional molecules of ClpS can bind to ClpA hexamers but they bind less tightly and total binding appears to be limited to ≤3 per hexamer. Binding of a single molecule of ClpS allows the maximum rate of degradation of N-end rule proteins by ClpAP and is sufficient to inhibit degradation of proteins lacking N-degrons. High affinity binding of the first ClpS molecule is lost when the first 17 amino acids of ClpS are removed, suggesting that part or all of the ClpS Nterminal peptide interacts with an additional site in ClpA hexamers. While the N-terminus of ClpS contributes to the interaction between the first ClpS molecule and ClpA 6 , a peptide consisting of residues 1-22 of ClpS is a weak inhibitor of casein and GFP-SsrA degradation (data not shown) and LR-GFP Venus degradation ( Supplementary Fig. S3 ), indicating that it has low intrinsic affinity for ClpA.
Where on ClpA the ClpS N-terminal peptide binds is not known. One possibility, also suggested by others (22) , is near the entrance or within the axial channel of the ClpA ring (Fig. 8 ).
Binding to a centrally located site would limit the number of tight binding ClpS molecules to one or two, because steric clashes would prevent multiple ClpS molecules from binding. Axial binding of the N-terminal peptide of ClpS should also tether the mobile N-domain to which ClpS is bound and position the N-recognin to which the substrate binds over the axial channel. Recent studies show that a segment of ≥4 amino acids between the Ndegron and the folded domain of a protein is necessary for efficient degradation by ClpAP and ClpS (5, 38) , and it is plausible that the positioning of ClpS with its bound substrate over the axial allows the unstructured portion of the substrate to be brought close to the surface of ClpA and thus facilitates its transfer to the interior unfolding apparatus of ClpA (Fig. 8) . The presence of the ClpS N-terminal peptide in the axial channel would also sterically block terminal peptide extensions or unstructured loops from other protein substrates from entering the channel and accessing the binding sites within ClpA. An alternative model is that the N-terminus of ClpS interacts with one or more of the other N-domains. In the co-crystal of ClpS and the ClpA N-domain, the ClpS N-terminal peptide was bound in a hydrophobic pocket of another N-domain molecule. Even transient interactions with the ClpS N-terminal peptide could bring the Ndomains together sufficiently to limit their accessibility to additional ClpS molecules and to substrates.
Truncations of the N-terminal 17 amino acids of ClpS are not tolerated for degradation of N-end rule proteins or for inhibition of non-N-end rule protein degradation; however, alanine scanning mutagenesis did not identify specific residues in the N-terminus that are essential for these functions (22) . Thus, it appears that, once ClpS is anchored to an N-domain, the presence of a relatively flexible N-terminal extension is sufficient to promote capture and uptake of the substrate bound to ClpS and to impede uptake of non-N-end rule substrates. Deletions beyond residue 17 eliminate both activities (15, 22) . Curiously, when 16 residues are deleted, the presence of a single bulky amino acid (methionine) at the N-terminus is sufficient to provide inhibitory activity but a smaller residue (valine) is not (22) , implying that the portion of the N-terminus of ClpS closer to the globular domain is essential for interaction with another site on ClpA.
Positioning substrates for efficient translocation through the axial channel of ClpA needs to occur in a manner that avoids steric clashes between substrates and avoids clogging the channels with multiple polypeptides seeking to enter at the same time. Evidence is accumulating that these conditions are met in ClpA and related ATPases, such as ClpX, in part by locating the high affinity binding sites for substrates within the axial channels themselves, where only a single polypeptide can have access (39) (35) (36) (37) 40, 41) . Substrate adaptors present potential problems, because the adaptors bind to the N-domains and in principle could deliver as many as six substrates at once. However, this dilemma is resolved for ClpAP and ClpXP by adaptor binding geometries that limit the number of substrate molecules that can be delivered simultaneously. SspB binds asymmetrically to ClpX hexamers despite its ability to bind stoichiometrically to isolated ClpX N-domain dimers (42) . The two interaction domains of the SspB dimer are bound to separate ClpX N-domain dimers, permitting one SspB dimer to occupy four of the six ClpX N-domains and allowing only one substrate molecule to be positioned close to the axial channel (42,43). As we discussed above, ClpS binding stoichiometry is limited by the N-terminal peptide, which interacts with a centrally located site in assembled ClpA. Thus, occlusion of the channel by bound substrate or a portion of the adaptor-substrate complex appears to be a common mechanism for limiting the number of substrates processed at any one time.
The contributions of the N-domains to binding and degradation of proteins, apart from serving as the docking site for adaptors, remain somewhat ill defined. ClpA lacking N-domains carry out most enzymatic functions quite efficiently and in some cases faster than the wild type enzyme, but the influence of the N-domains on degradation is distinctly substrate-dependent. N-domains reduce the degradation rate for both casein, which does not require unfolding, and for GFP-SsrA, which does require unfolding, suggesting that the rate limiting step in degradation when the N-domains are present is not substrate unfolding. The lack of an effect on the K m for GFP-SsrA or RepA indicates that the N-domains do not affect the on-rate for either substrate, and thus initial substrate binding does not appear to be rate limiting. We favor a model in which the N-domains interact with proteins as they are unfolded on ClpA and retard the hand-off from D1 to D2 and thus reduce the overall rate of translocation. With RepA, the Ndomains appear to have no effect on the rate of degradation, although it has been reported that RepA can interact with the N-domains. However, RepA binding to ClpA proceeds in two steps, a fast reversible step and a slower "committed" step (44) . In separate experiments, we have found that RepA also forms committed complexes with ClpA-Δ153, and the latter step is most likely rate limiting in RepA degradation. From the above discussion, it is clear that that the N-domains have multiple modes of interaction with substrates and their effects on substrate binding, unfolding, and degradation vary with the nature of the protein substrate.
In E. coli cells, ClpS restricts the activity of ClpAP to protein substrates with an accessible Ndegron. Measurements of the intracellular levels of ClpA and ClpS and the stability of ClpA in vivo suggest that ClpA is not saturated with ClpS under all conditions. ClpA hexamers and ClpS are present in exponentially growing cells at concentrations in the range of 100-200 nM (45, 46) , which would mean that ~75% of ClpA hexamers will have ClpS bound. ClpS protects ClpA from autodegradation, but more than half of the ClpA is degraded per generation in cells expressing endogenous levels of ClpA and ClpS (22) , suggesting that not all the ClpA has ClpS bound in vivo. Thus, it is likely that both ClpAP and ClpAP/ClpS complexes are available to target their selective substrates, and that at least part of the time both systems operate simultaneously. Direct measurement of the effects of ClpS on degradation of non-N-end rule substrates is consistent with this model (46, 47) . While substrates specifically regulated by ClpS-mediated degradation via the N-end rule have recently been identified (9,11) endogenous substrates that are primarily targeted by ClpAP are yet unknown.
ClpA and ClpX levels are nearly the same in E. coli cells (45) and both enzymes have similar activity in vitro, so the expectation is that they would have similar numbers of substrates in vivo. It is not known whether N-end rule substrates are only generated by specific regulatory processes or can also arise as a result of damage or errors in transcription or translation. It seems plausible that N-end rule proteins might occur at least as often as SsrA-tagged proteins, and that the levels would reflect particular stress conditions or nutritional deficiencies. Whether there are regulatory targets for ClpAP, independent of ClpS, is still an open question.
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The authors thank Dr. Grzegorz Piszczek in the Biophysics Unit of NHLBI, NIH for advice and use of the microcalorimeter and Drs. Jan Rozycki and Agnieszka Szyk, LCB, NCI for synthesis of several peptides. This research was supported by the Intramural Research Program of the National Cancer Institute, NIH, Center for Cancer Research. D) . For the co-migration assays, ClpS or ClpS-Δ17 was added in various stoichiometric ratios to 1 µM ClpA 6 in 50 mM Tris/HCl, pH 7.5, 0.1 M KCl, 10% (v/v) glycerol, 2 mM ATPγS and 25 mM MgCl 2 . The mixtures were run over a Superdex200 column in the same solution. Equal aliquots of fractions were subjected to SDS/PAGE, digital images of the Coomassie blue-stained gels were recorded, and the distribution of ClpS or ClpS-ΔN17 was determined (Materials and Methods). A, ClpS and ClpA 6 in a ratio of 1:1 (circles); 3:1 (triangles); and 6:1 (squares); fraction sizes were 80 µl each. C, ClpS-Δ17 and ClpA 6 at a ratio of 1:1 (circles); 3:1 (triangles); 6:1 (squares); and 12:1 (inverted triangles); fraction sizes were In each series, the LR-GFPVenus concentration was held constant at 11 µM and the ClpS concentrations (expressed as equivalents of ClpA 6 ) were varied. The observed specific activities (µmol substrate/µmol ClpA 6 /min) versus ClpS concentration are plotted. At ClpA concentrations below the K d for dissociation with ClpS, higher amounts of ClpS are required to saturate the ClpA and achieve maximum specific activity. At 400 nM ClpA 6 , only one equivalent of ClpS is needed to achieve maximum activity of ClpA 6 and higher concentration begin to show inhibitory effects, presumably because, at free ClpS concentrations >1 µM, competition with the ClpA/ClpS complex for substrate binding becomes significant. Circles, 100 nM ClpA 6 ; squares, 200 nM ClpA 6 ; diamonds, 300 nM ClpA 6 ; inverted triangles, 400 nM ClpA 6 . B, Degradation of LR-GFP Venus by ClpAP was measured with different ratios of ClpA and ClpS; circles, 100 nM ClpA 6 and100 nM ClpS; squares, 100 nM ClpA 6 and 200 nM ClpS; diamonds, 100 nM ClpA 6 and 600 nM ClpS; inverted triangles, 400 nM ClpA 6 and 400 nM ClpS. In each series, the specific activity (µmol substrate/µmol ClpA 6 /min) is plotted as a function of substrate (LR-GFP Venus ) concentration. The apparent K m for LR-GFP Venus did not change suggesting that the active species is the same with different ratios of ClpS and ClpA 6 . The minimum value for K m /k cat is achieved with a one to one stoichiometry of ClpS to ClpA 6 . binds to one of the six N-domains on ClpA using the interface observed in the co-crystal of ClpS and the isolated ClpA N-domain (15, 21) . Substrates with N-degrons (gold) interact with a specific binding site on ClpS and are delivered to ClpA for processing. ClpS excludes substrates lacking N-degrons (brown) by blocking access to other sites within ClpA. The flexible N-terminal portion of ClpS also contributes to binding; however, only one ClpS-N-terminal peptide can utilize this site at a time, thus restricting ClpS to one high-affinity binding interaction per hexamer of ClpA. The region around residue 17 of ClpS appears to be needed for this secondary interaction, although it is not known whether it interacts on the surface of ClpA-D1 near the axial channel (upper path) or with other ClpA N-domains (lower path). 
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